Showing 1 - 10 results of 10 for search 'Wen‐Jie Wu', 查询时间: 0.03s
Refine Results
-
1
-
2
-
3
Tislelizumab plus nimotuzumab is effective against recurrent or metastatic oral squamous cell carcinoma among patients with a performance status score ≥ 2: a retrospective study 由 Wen-Jie Wu, Wen-Jie Wu, Wen-Jie Wu, Pu-Gen An, Pu-Gen An, Pu-Gen An, Yi-Wei Zhong, Yi-Wei Zhong, Yi-Wei Zhong, Xiao Hu, Xiao Hu, Xiao Hu, Lin Wang, Lin Wang, Lin Wang, Jie Zhang, Jie Zhang, Jie Zhang
出版 2024-01-01
文件 -
4
Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: a real−world retrospective study 由 Wen-Jie Wu, Wen-Jie Wu, Wen-Jie Wu, Qian Liu, Qian Liu, Qian Liu, Pu-Gen An, Pu-Gen An, Pu-Gen An, Lin Wang, Lin Wang, Lin Wang, Jian-Yun Zhang, Jian-Yun Zhang, Jian-Yun Zhang, Yan Chen, Yan Chen, Yan Chen, Tong Zhang, Jie Zhang, Jie Zhang, Jie Zhang
出版 2023-11-01
文件 -
5
Corrigendum: Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: a real−world retrospective study 由 Wen-Jie Wu, Wen-Jie Wu, Wen-Jie Wu, Qian Liu, Qian Liu, Qian Liu, Pu-Gen An, Pu-Gen An, Pu-Gen An, Lin Wang, Lin Wang, Lin Wang, Jian-Yun Zhang, Jian-Yun Zhang, Jian-Yun Zhang, Yan Chen, Yan Chen, Yan Chen, Tong Zhang, Jie Zhang, Jie Zhang, Jie Zhang
出版 2024-01-01
文件 -
6
-
7
-
8
-
9
-
10
Qualitative and Quantitative Analysis of Ejiao-Related Animal Gelatins through Peptide Markers Using LC-QTOF-MS/MS and Scheduled Multiple Reaction Monitoring (MRM) by LC-QQQ-MS/MS 由 Wen-Jie Wu, Li-Feng Li, Hau-Yee Fung, Hui-Yuan Cheng, Hau-Yee Kong, Tin-Long Wong, Quan-Wei Zhang, Man Liu, Wan-Rong Bao, Chu-Ying Huo, Shangwei Guo, Haibin Liu, Xiangshan Zhou, Deng-Feng Gao, Quan-Bin Han
出版 2022-07-01
文件